ANGIOTENSIN-II PARTICIPATES IN MONONUCLEAR CELL RECRUITMENT IN EXPERIMENTAL IMMUNE-COMPLEX NEPHRITIS THROUGH NUCLEAR FACTOR-KAPPA-B ACTIVATION AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 SYNTHESIS
M. Ruizortega et al., ANGIOTENSIN-II PARTICIPATES IN MONONUCLEAR CELL RECRUITMENT IN EXPERIMENTAL IMMUNE-COMPLEX NEPHRITIS THROUGH NUCLEAR FACTOR-KAPPA-B ACTIVATION AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 SYNTHESIS, The Journal of immunology (1950), 161(1), 1998, pp. 430-439
Angiotensin-converting enzyme (ACE) inhibitors reduce macrophage infil
tration in several models of renal injury. We approached the hypothesi
s that angiotensin II (AngII) could be involved in inflammatory cell r
ecruitment during renal damage through the synthesis of monocyte chemo
attractant protein-1 (MCP-1). In a model of immune complex nephritis,
we observed an up-regulation of renal MCP-1 (mRNA and protein) coincid
entally with mononuclear cell infiltration that were markedly reduced
by treatment with the ACE inhibitor quinapril. Exposure of cultured ra
t mesangial cells to AngII increased MCP-1 mRNA expression (2.7-fold)
and synthesis (3-fold), similar to that observed with TNF-alpha. Since
NF-kappa B is involved in the regulation of MCP-1 gene, we explored w
hether the effects of AngII were mediated through NF-kappa E activatio
n. Untreated nephritic rats showed increased renal NF-kappa B activity
(3.5-fold) that decreased in response to ACE inhibition. In mesangial
cells, AngII activated NF-kappa B (4.3-fold), and the NF-kappa B inhi
bitor pyrrolidine dithiocarbamate abolished the AngII-induced NF-kappa
B activation and MCP-1 gene expression. Our results suggest that AngI
I could participate in the recruitment of mononuclear cells through NF
-kappa B activation and MCP-1 expression by renal cells, This could be
a novel mechanism that might further explain the beneficial effects o
f ACE inhibitors in progressive renal diseases.